• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Investigation of mechanism of infarct size-reducing effect of α-1,6-glucosidase inhibitor

Research Project

Project/Area Number 10670639
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionGifu University

Principal Investigator

MINATOGUCHI Shinya  Gifu University, Medicine, Associate Professor, 医学部, 助教授 (20190697)

Co-Investigator(Kenkyū-buntansha) FUJIWARA Hisayoshi  Gifu University, Medicine, Professor, 医学部, 教授 (80115930)
野田 俊之  岐阜大学, 医学部附属病院, 講師 (00262759)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥3,200,000 (Direct Cost: ¥3,200,000)
Fiscal Year 1999: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 1998: ¥2,000,000 (Direct Cost: ¥2,000,000)
Keywordsα-glucosidases inhibitor / myocardial infarction / stunning / apoptosis / glycogen / lactate / α-グルマシダーゼ阻害薬 / グリマーゲン / α-1,6-glucosidase / protein kinase C / glycogen / N-methyl-1-deoxynojirimycirn / lactate
Research Abstract

1) N-methyl-1-deoxynojirimycin (NMDM) and α-1,6-glucosidase activity, glyconen and lactate
In an in vitro study of rabbit heart, NMDM inhibited the α-1,6-glucosidase activity in a dose dependent manner. In an in vivo rabbit model, NMDM (100mg/kg, i.v.) inhibited the α-1,6-glucosidase activity without affecting phosphorylase activity during ischemia, and inhibited the breakdown myocardial glycogen and the lactate accumulation.
2) NMDM and protein kinase C
The infarct size-reducing effect of NMDM (100 mg/kg, i.v.) was complelely blocked by pretreatment with protein kinase C inhibitor staurosporine (50 μg/kg i.v.). Translocation of the PKC-ε, one of the subtypes of protein kinase C, by NMDM was observed during ischemia by western blotting method.
3) NMDM and apoptosis
The percentage of TUNEL-positive myocytes in the infarcted area of the rabbits with 30 min ischemia and 4 hour reperfusion was significantly reduced in the NMDM group (3.8±1.5 %) as compared with control group (10.7±1.9 %).
4) NMDM and stunning
NMDM (100 mg/kg, i.v.) significantly improved the regional myocardial contractile function in a 10 min-ischemia and reperfusion model of rabbits. This suggests that NMDM improves stunning.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (4 results)

All Other

All Publications (4 results)

  • [Publications] Masazumi Arai, Shinya Minatoguchi, et al: "N-Methyl-1-Deoxynojirimycin(MCR-14), an α-Glycosidase inhibitor, Markedly Reduced Infant Size in Rabbit Hearts"Circulation. 97. 1290-1297 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Arai M, et al.: "N-Methyl-1-Deoxynojirimycin (MOR-14), an α-Glucosidase Inhibitor, Markedly Reduced Infarct Size in Rabbit Hearts"Circulation. 97. 1290-1297 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Masazumi Arai,Shinya Minatoguchi et al.: "N-methyl-1-Deoxynojirimycin(MOR-14),in α-Glucosidase inhibitor,Markedly Reduced Infant Size in Rabbit Hearts"Circulation. 97. 1290-1297 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] M.Arai, S Minatoguchi: "N-Methyl-1-Deaxynojirimycin (MOR-14), an α Gluresidase Inhibitor, Markedly Reduced the lufarct Size in Rabbit Hearts." Circulation. 97. 1290-1297 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi